Bone-Building Drugs Could Restore Teeth in Diabetes
Adults with type 2 diabetes may one day benefit from bone therapies, though the mouse study has not yet been tested in people.
Updated on Nov. 12, 2026 in Diabetes

Researchers report that parathyroid hormone (PTH) and abaloparatide restored alveolar bone, the bone that anchors teeth, in mice with established type 2 diabetes. The findings were published in the International Journal of Oral Science on 29 October 2026.
Why it matters
Type 2 diabetes drives alveolar bone loss, which contributes to tooth loosening and tooth loss, and people with diabetes face a substantially higher risk of periodontitis. The study points to a possible bone-building approach for this specific problem, though it has so far been tested only in mice.
This is a preclinical study in mice with diet- and drug-induced type 2 diabetes, comparing PTH and abaloparatide treatment against untreated diabetic and non-diabetic controls. The measured outcome was restored alveolar bone height and bone volume, and the authors note that the work has not yet been tested in humans.
The players
Indiana University School of Medicine
A U.S. medical school whose researchers led the study on bone and dental health in diabetes.
University of Arkansas for Medical Sciences
A U.S. academic medical center whose researchers co-led the study on diabetes-related bone loss.
The details
PTH and abaloparatide act on the PTH1R receptor, and the study found that signaling in osteocytes, the cells embedded in bone, drives the bone-building effect. These treatments suppressed sclerostin and Dickkopf-1 in osteocytes, which activated Wnt signaling, a pathway that promotes bone formation. The researchers also found that PTH1R signaling in marrow cells promotes bone resorption by raising RANKL and lowering OPG, which helps explain why the treatments produce a net gain only in the diabetic setting.
Timeline
29 October 2026: Study published in the International Journal of Oral Science.
Health Landscape
Parathyroid hormone and abaloparatide are existing bone-building therapies that have been used mainly for osteoporosis, so this work tests whether they can address a different skeletal problem. It adds to growing attention on the oral health complications of type 2 diabetes, where periodontitis and tooth loss are common.
If you have type 2 diabetes, loosening teeth or gum problems are worth raising with your dentist and doctor, since diabetes raises the risk of periodontitis. This research is at the mouse stage, so no treatment change is available yet, and any question about bone-building therapies is best discussed with your physician.
The takeaway
Diabetes can weaken the bone that holds teeth in place, and this mouse study suggests that bone may be rebuildable. If you have diabetes, keep up regular dental checkups and mention any gum changes or tooth looseness to your care team.
Further reading
For broader context on how the condition affects the body, explore our Diabetes coverage.
More information
Read the full published study in the International Journal of Oral Science.


